Biote (BTMD) Revenue (2021 - 2026)

Biote has reported Revenue for 6 years, with the latest figure at $44.9 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 8.28% year-over-year to $44.9 million; the trailing twelve-month figure through Mar 2026 stood at $188.2 million (down 5.63% YoY), and the FY2025 full-year result was $192.2 million, down 2.52% from the prior year.
• Revenue for Q1 2026 stood at $44.9 million, down from $46.4 million in the prior quarter.
• The five-year high for Revenue was $51.4 million in Q3 2024, with the low at $37.1 million in Q1 2022.
• Average Revenue over 5 years is $46.2 million, with a median of $46.4 million recorded in 2025.
• Year-over-year, Revenue rose 20.73% in 2023 and declined 8.28% in 2026.
• Tracing BTMD's Revenue over 5 years: stood at $44.5 million in 2022, then grew by 2.74% to $45.7 million in 2023, then gained by 9.04% to $49.8 million in 2024, then retreated by 6.87% to $46.4 million in 2025, then slipped by 3.17% to $44.9 million in 2026.
• The last three Revenue figures came in at $44.9 million (Q1 2026), $46.4 million (Q4 2025), and $48.0 million (Q3 2025), per Business Quant data.

Peer Comparison